Julien Baker and Mackenzie Scott (a.k.a Torres) are indie singer-songwriters with Southern roots. Baker is from Memphis, and Torres hails from Macon, Georgia. They’ve both always been excellent ...

Brazilian influencer Kat Torres rose to fame on social media because of her wellness content — but things took a sinister turn. Torres, who is currently incarcerated, had millions of social ...

Gleyber Torres’ first home run with the Tigers came at a cost. The former Yankees infielder aggravated recent soreness in his lower ribs Friday while going deep off Dodgers starter Yoshinobu ...

April 18 (UPI) --Singer-songwriter Torres is releasing a new album with Julien Baker, and she says the country record represents a return to her Georgia roots. The album, Send a Prayer My Way ...

Torres (oblique) is expected to be activated from the 10-day injured list Friday, Chris McCosky of The Detroit News reports. Torres strained his oblique March 28 but appears to be ready to return ...

Gleyber Torres returns from the injured list to the Detroit Tigers' starting lineup. Torres' return creates a position player logjam, giving manager A.J. Hinch options at first, second ...

There were months of uncertainty about what Julien Baker and Torres were up to, even before they performed together on The Tonight Show in December 2024. It was only in late January that they made ...

Torres aggravated a rib injury during Friday's game against the Dodgers, Jeff Seidel of The Detroit Free Press reports. Torres was grabbing at his left side after hitting a home run in the third ...

Julien Baker and Torres have shared their new song “Dirt,” the latest single from their upcoming collaborative album Send a Prayer My Way. “Sometimes it makes me feel better/Sometimes it ...

The Detroit Tigers signed former New York Yankees second baseman Gleyber Torres this past offseason, and for good reason. While Torres may not thrive under Manhattan's lights, he is a more than ...

Our preliminary revenue for the first quarter met our expectations despite impacts from ongoing uncertainty in NIH funding in the United States and broader economic headwinds affecting the industry.